MBA

Orinova, A cosmeceutical division of Origo Pharmaceuticals Pvt. Ltd. Orinova objective is - Discover the beauty. We believe in bringing super specialty innovative cosmeceuticals products for discovering the beauty from inside.

Ontop Pharmaceuticals, New Delhi, is a established house in the field of pharmaceutical manufacturing with many a path breaking innovations to its credit. The company is envisaging a foray into the marketing of premium functional cosmetics. For this venture the company requires diligent, imaginative & result oriented;

Post: Product Managers

Emcure is one of the most progressive Pharma companies with a spectacular track record. Our indigenous chiral molecules and our brands like Orofer-XT, Asomex, Metpure XL are synonymous with Anaemia Management & Hypertension respectively & we have attained leadership position amongst Calcium Channel blockers.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

With a history spanning more than half a century, Advanced Enzymes Technologies Ltd (Advanced Enzymes) has emerged as a worldwide leader in the production of plant, microbial and animal-based enzymes. In 1957, our founder, Mr. L.C. Rathi, pioneered the extraction of papain, an enzyme complex derived from papaya fruit and widely used for pharmaceutical and medical purposes.

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

Olefia Biopharma Limited, We would like to introduce ourselves as one of the most rapidly emerging FMCG Company in various fields of Pharmaceutical, Cosmetics, Ayurvedics / herbals and biotech.
Olefia Biopharma Limited is utilising MHRA and WHO-GMP Approved manufacturing unit to manufacture various Tablets, Capsule, Syrups, Suspensions and other formulations for its various division viz. Pharmaceutical and Cosmetic i.e. FMCG and exporting to various countries across the Globe.

Mokshagundam Vishveshwarya was born on August 28, 1860 and Muddenahalli(a village) in Chikballapur Taluk, Kolar district, Mysore (Now Karnataka). Vishveshwarya completed his lower secondary course at Chikballapur. After completing his high-school, he joined the central college having stood first in engineering, it was not difficult for him to enter the Bombay Government Service. He joined the engineer's kader as an Assistant Engineer.

About Author:
Mr. Jagmohan Rai Agarwal,
M.Pharm (1968), Industrial experience SSI sector, nearly 37 years, retired from own Industry,
Founder President of M.P.Pharmacy Graduates’ Association,
President: M.P.Pharmaceutical Manufacturers’ Organisation,
Founder President : M.P. Small Scale Drug Manufacturers’ Association,
President Indian Pharmaceutical Association, M.P. State Branch, Indore,
Recently submitted thesis for award of  Ph.D. on title “Enforcement of Drug Laws-Globalization vis-à-vis Indian Drug Laws”
(Email: sharda_jollo@yahoo.co.in)

Quality of Pharmaceuticals has been a concern of the World Health Organisation (WHO) since its inception. The setting of global standards is requested in Article 2 of the WHO constitution which sites as one of the organisation’s functions that it should develop, establish and promote International standards with respect to food, biological, pharmaceuticals and similar products.

Campbell (US FDA) was the first leading architect of the present Federal Food, Drug and Cosmetics Act passed in 1938. He differed sharply with ‘Willey’ in his belief that Court proceedings were not the only proper way to secure compliance.